Social anxiety common in remitted schizophrenia patients

NewsGuard 100/100 Score

By Mark Cowen, Senior medwireNews Reporter

Social anxiety is common in schizophrenia patients who are in remission and is associated with reduced quality of life, Japanese study results show.

Hiroyuki Kobayashi (Keio University, Tokyo) and team found that although most symptoms improve over time in remitted patients with schizophrenia, social anxiety symptoms often worsen.

"To achieve a complete functional recovery, additional interventions for social anxiety may be needed," they comment in Comprehensive Psychiatry.

The findings come from a 5-year follow-up study of 36 remitted schizophrenia patients who were aged an average of 60.3 years with a mean illness duration of 27.6 years.

All of the participants were assessed at baseline and follow-up using the Liebowitz Social Anxiety Scale (LSAS), the World Health Organization Quality of Life 26 (WHO-QOL26) scale, the Positive and Negative Syndrome Scale (PANSS), and the Global Assessment of Functioning (GAF) scale.

The researchers found that although mean PANSS scores improved and GAF scores remained stable, mean LSAS scores worsened during follow up, increasing from 38.6 to 46.4.

Indeed, 24 (67%) patients had a mean LSAS total score higher than 30 at follow up, suggesting that their social anxiety symptoms had reached a clinical level.

The researchers also found that patients whose LSAS scores worsened over the study period had significantly lower WHO-QOL26 scores at follow up than those whose LSAS scores had remained stable, at 74.4 versus 84.2.

Logistic regression analysis revealed that quality of life at baseline and follow up was negatively associated with social anxiety symptoms.

Kobayashi and team conclude: "The present findings revealed that social anxiety symptoms were commonly reported among elderly patients with remitted schizophrenia after hospital discharge and that the development of social anxiety symptoms was not associated with psychotic symptoms or social functioning, but with subjective quality of life."

They add: "The current study provides a new and important perspective on social anxiety in individuals with schizophrenia."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

  1. Ron Schraiber Ron Schraiber United States says:

    The label of schizophrenia carries with it tremendous stigma, prejudice and discrimination in society.  Why should not individuals who have been diagnosed with schizophrenia that puts them into a marginalized pariah status not have anxiety about being accepted into and by society, in general?  Stereotypical attitudes are not primarily a function of individual behavior but of permeating cultural and societal prejudice and discrimination. Historically, similar to African-Americans, Gypsies, Jews,or people labeled as epileptics or leper have had good reason to be anxious about being treated as full and respected human beings in the communities they have lived. Why wouldn't a person have social anxiety when their groups, such as people diagnosed with schizophrenia, are common objects of derision and fear, and where neighborhoods file lawsuits and staged hateful protests to keep you out of their neigborhood. Being the "Other" will naturally cause social anxiety and should not be so easily pathologized and decontexualized from societal prejudice and discrimination as does psychiatric diagnosis and research does.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Probiotics plus vitamin D supplements may improve cognitive function in individuals with schizophrenia